This inventor holds 3 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Andernach, DE (2018 - 2021)
- Mendig, DE (2022)
Company Filing History:
Years Active: 2018-2022
Title: The Innovations of Nico Reum
Introduction
Nico Reum is a notable inventor based in Andernach, Germany. He has made significant contributions to the field of transdermal therapeutic systems, holding a total of 3 patents. His work focuses on innovative methods for drug delivery, particularly in the administration of rivastigmine.
Latest Patents
One of his latest patents is a transdermal therapeutic system for the transdermal administration of rivastigmine. This invention comprises a rivastigmine-containing layer structure, which includes a backing layer and a rivastigmine-containing layer. Another significant patent involves a transdermal therapeutic system that incorporates an electronic component, along with methods for producing such systems. These innovations highlight his commitment to advancing medical technology.
Career Highlights
Nico Reum is associated with LTS Lohmann Therapie-Systeme AG, a company known for its expertise in transdermal drug delivery systems. His role at the company has allowed him to develop and refine his inventions, contributing to the advancement of therapeutic solutions.
Collaborations
Throughout his career, Nico has collaborated with several professionals, including Wolfgang Laux and Beatrix Platt. These collaborations have fostered a creative environment that encourages innovation and the development of new technologies.
Conclusion
Nico Reum's contributions to the field of transdermal therapeutic systems demonstrate his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to enhancing drug delivery methods, making a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile